Swanton Robert Charles bought BCYC
August 12, 2025 · Form 4 insider transaction
Swanton Robert Charles bought 12,500 shares of Bicycle Therapeutics plc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
12,500
Price
$0.00
Total value
N/A
InsiderSwanton Robert Charles
RoleDirector
SecurityOrdinary Shares
Transaction codeA: Grant or award
Transaction dateAugust 12, 2025
Filing dateAugust 14, 2025
Shares owned after15,589
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a restricted share unit ("RSU") award. The RSUs will vest in three equal installments on each of August 12, 2026, August 12, 2027 and August 12, 2028.; Each RSU represents a contingent right to receive one ordinary share.